Clinical Trial Update: Cisplatin+Pembrolizumab+RT in Vulvar Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating cisplatin plus pembrolizumab and radiotherapy in vulvar cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vulvar Cancer
• Vulvar Squamous Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)
• Platinol (cisplatin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Vulvar Cancer, Vulvar Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING